| Literature DB >> 27136471 |
Marcos Tobias-Machado1, Anuar Ibrahim Mitre2,3, Mauricio Rubinstein4, Eduardo Fernandes da Costa5, Alexandre Kyoshi Hidaka5.
Abstract
BACKGROUND: Robotic-assisted radical prostatectomy (RALP) is a minimally invasive procedure that could have a reduced learning curve for unfamiliar laparoscopic surgeon. However, there are no consensuses regarding the impact of previous laparoscopic experience on the learning curve of RALP. We report on a functional and perioperative outcome comparison between our initial 60 cases of RALP and last 60 cases of laparoscopic radical prostatectomy (LRP), performed by three experienced laparoscopic surgeons with a 200+LRP cases experience.Entities:
Mesh:
Year: 2016 PMID: 27136471 PMCID: PMC4811230 DOI: 10.1590/S1677-5538.IBJU.2014.0485
Source DB: PubMed Journal: Int Braz J Urol ISSN: 1677-5538 Impact factor: 1.541
Preoperative patient characteristics. The groups were similar in terms of age, PSA level, Gleason grade, nerve sparing and pathologic stage (T2, T3).
| LRP | RALP | P value | |
|---|---|---|---|
|
|
| ||
|
| |||
| Age (range, SD) years | 60.56±11.6 | 60.58±7.94 | 0.99 |
| PSA (range, SD) ng/mL | 7.05±3.70 | 6.17±2.63 | 0.13 |
|
| |||
|
| 46.25% | 46.6% | 0.96 |
|
| 35.00% | 45.0% | 0.26 |
|
| 18.75% | 8.4% | 0.09 |
|
| |||
|
| 87.20% | 81.6% | 0.74 |
|
| 12.80% | 18.4% | 0.4 |
|
| |||
| Unilateral | 26.7% | 16.7% | 0.18 |
| Bilateral | 73.3% | 83.3% | 0.18 |
Perioperative outcomes. Robotic-assisted radical prostatectomy presented longer operative time and higher blood loss when compared to LRP.
| LRP | RALP | P value | |
|---|---|---|---|
|
|
| ||
|
| |||
|
| 153.51±41.8 | 236.1±42.95 | <0.001 |
|
| 202±73.3 | 245.6±33.71 | <0.001 |
|
| 10.30% | 6.6% | 0.46 |
|
| 1.38 | 1.60 | 0.92 |
|
| 0% | 0% | 1.0 |
Functional and oncological outcomes. Robotic-assisted radical prostatectomy presented higher percentage of potency continence at six months and positive surgical margins.
| LRP | RALP | P value | |
|---|---|---|---|
|
|
| ||
|
| |||
| Continence rates at six month (%) | 89.3% | 93.3% | 0.43 |
| Potency rates at six month (%) | 50% | 70% | 0.02 |
| Positive Surgical Margins (%) | 12.5% | 21.6% | 0.18 |
| pT2 | 8% | 12.5% | 0.7 |
| pT3 | 33% | 50% | 0.1 |